Cite
HARVARD Citation
Carazo, S. et al. (2022). Single-Dose Messenger RNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Workers Extending 16 Weeks Postvaccination: A Test-Negative Design From Québec, Canada. Clinical infectious diseases. pp. e805-e813. [Online].